엘레돈 파마슈티컬스, Inc.
DE ˙ DB ˙ US28617K1016
€2.92 ↓ -0.04 (-1.35%)
2026-06-04
주가
SecurityDE:2TK / Eledon Pharmaceuticals, Inc.
InstitutionBvf Inc/il
Latest Disclosed Ownership6,293,282 shares
Latest Disclosed Value $ 19,383,309
Bvf Inc/il ownership in 2TK / Eledon Pharmaceuticals, Inc.

On May 15, 2026 - Bvf Inc/il filed a 13F-HR form disclosing ownership of 6,293,282 shares of Eledon Pharmaceuticals, Inc. (DE:2TK) valued at $14,474,549 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 6,293,282 shares of Eledon Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $18,376,383 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 0 0.00 19,383 103.99 0.6175
2026-02-17 2025-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 0 0.00 9,503 -41.70 0.3199
2025-11-14 2025-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 0 0.00 16,300 -4.43 0.6607
2025-08-14 2025-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 0 0.00 17,055 -20.06 0.6093
2025-05-15 2025-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 0 0.00 21,334 -17.72 0.8695
2025-02-14 2024-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 0 0.00 25,928 65.46 0.8787
2024-11-14 2024-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 0 0.00 15,670 -5.68 0.4584
2024-08-14 2024-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 6,293,282 1,966,572 45.45 16,614 86.40 0.4656
2024-05-15 2024-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 4,326,710 0 0.00 8,913 14.45 0.2450
2024-02-14 2023-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 4,326,710 0 0.00 7,788 31.40 0.1949
2023-11-14 2023-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 4,326,710 0 0.00 5,928 0.00 0.1598
2023-08-14 2023-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 4,326,710 2,000,000 85.96 5,928 7.94 0.1652
2023-05-15 2023-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 2,326,710 0 0.00 5,491 1.74 0.2007
2023-02-14 2022-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 2,326,710 0 0.00 5,398 -15.96 0.2278
2022-11-14 2022-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 2,326,710 0 0.00 6,422 13.12 0.2653
2022-08-15 2022-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 2,326,710 0 0.00 5,677 -38.07 0.2742
2022-05-16 2022-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 2,326,710 948,690 68.84 9,167 50.85 0.3667
2022-02-14 2021-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 1,378,020 14,585 1.07 6,077 -27.88 0.2206
2021-11-15 2021-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 1,363,435 250,000 22.45 8,426 -4.33 0.3287
2021-08-16 2021-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 1,113,435 0 0.00 8,807 -26.08 0.3301
2021-05-17 2021-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 1,113,435 350,156 45.88 11,914 1.36 0.4467
2021-02-12 2020-12-31 13F NOVUS THERAPEUTICS COM 67011N204 763,279 -2,752,594 -78.29 11,754 251.92 0.4624
2020-11-13 2020-09-30 13F NOVUS THERAPEUTICS COM 67011N105 3,515,873 1,730,873 96.97 3,340 308.31 0.1819
2020-08-14 2020-06-30 13F NOVUS THERAPEUTICS COM 67011N105 1,785,000 1,100,187 160.66 818 206.37 0.0504
2020-05-15 2020-03-31 13F NOVUS THERAPEUTICS COM 67011N105 684,813 -144,063 -17.38 267 -44.49 0.0249
2020-02-14 2019-12-31 13F NOVUS THERAPEUTICS COM 67011N105 828,876 0 0.00 481 -7.85 0.0365
2019-11-14 2019-09-30 13F NOVUS THERAPEUTICS COM 67011N105 828,876 0 0.00 522 -37.63 0.0548
2019-08-14 2019-06-30 13F NOVUS THERAPEUTICS COM 67011N105 828,876 828,876 837 0.0914
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.